| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/08/2014 | CN103501815A A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use |
| 01/08/2014 | CN103501814A Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| 01/08/2014 | CN103501801A Parathyroid hormone analogs, compositions and uses thereof |
| 01/08/2014 | CN103497254A Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 01/08/2014 | CN103497253A Nanometer antibody, encoding sequence and application of H2A.Z variant |
| 01/08/2014 | CN103497252A Single-domain heavy chain antibody L5-78 for Listeria monocytogenes |
| 01/08/2014 | CN103497251A Single-domain heavy chain antibody L5-79 for Listeria monocytogenes |
| 01/08/2014 | CN103497250A WSSA (white spot syndrome virus disease) double-antibody sandwiched ELISA (enzyme linked immunosorbent assay) detection kit |
| 01/08/2014 | CN103497249A Preparation of baculovirusHearNPV LEF-9 protein polyclonal antibody |
| 01/08/2014 | CN103497248A Method for separating and purifying antibody from cell culture supernatant |
| 01/08/2014 | CN103497241A Prawn anti-viral Argonaute protein, as well as encoding cDNA (complementary deoxyribonucleic acid) and application thereof |
| 01/08/2014 | CN103495165A Method of administering anti-TNFalpha antibodies |
| 01/08/2014 | CN102731616B Tetanus-toxin-neutralizing B cell epitope peptide and application thereof |
| 01/08/2014 | CN102659937B Preparation method and application of recombinant protein and monoclonal antibody thereof |
| 01/08/2014 | CN102659929B Transient receptor potential channel-6 (TRPC6) antigen polypeptide and anti-TRPC6 monoclonal antibody |
| 01/08/2014 | CN102399289B Human IgE (immunoglobulin E) Fab (fragment ab) against human and coding gene and application thereof |
| 01/08/2014 | CN101600457B Anti-il-13 antibody formulations and uses thereof |
| 01/08/2014 | CN101528776B An ultra-high yield intravenous immune globulin preparation |
| 01/08/2014 | CN101495138B Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof |
| 01/08/2014 | CN101432301B Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/08/2014 | CA2832097A1 Mecp2 isoform-specific antibody for detection of endogenous expression of mecp2e2 |
| 01/07/2014 | US8624013 Interleukin-10 antibodies |
| 01/07/2014 | US8624012 Nucleic acids encoding T2R bitter taste receptors |
| 01/07/2014 | US8624007 Alteration of Fc-fusion protein serum half-lives by mutagenesis |
| 01/07/2014 | US8624005 Method of protein refolding with ion exchange resins and the application of the same |
| 01/07/2014 | US8624003 Methods for preparation of antibody-maytansinoid conjugates |
| 01/07/2014 | US8624002 Prostaglandin E2 binding proteins and uses thereof |
| 01/07/2014 | US8624001 Anti-CD19 antibodies |
| 01/07/2014 | US8623644 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/07/2014 | US8623594 Methods for isolation of antibody binding to cells |
| 01/07/2014 | US8623373 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 01/07/2014 | US8623372 Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
| 01/07/2014 | US8623369 Anti-ICAM-1 single domain antibody and uses thereof |
| 01/07/2014 | US8623368 Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
| 01/07/2014 | US8623367 Antibody formulation |
| 01/07/2014 | US8623366 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| 01/07/2014 | US8623365 Aβ binding molecules |
| 01/07/2014 | US8623364 Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 01/07/2014 | US8623360 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 01/07/2014 | US8623357 Therapeutic antibodies |
| 01/07/2014 | US8623355 Methods for suppressing acute rejection of a heart transplant |
| 01/07/2014 | US8623354 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 01/07/2014 | US8623353 TLR2 antagonistic antibody and use thereof |
| 01/07/2014 | CA2570407C Methods and compositions for modulating stem cell growth and differentiation |
| 01/07/2014 | CA2563117C Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor |
| 01/07/2014 | CA2512657C Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 01/07/2014 | CA2464472C Antibody targeting compounds |
| 01/07/2014 | CA2461372C Dna sequences for human angiogenesis genes |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/07/2014 | CA2318405C Antibodies to death receptor 4(dr4) and uses thereof |
| 01/03/2014 | WO2014004694A1 Reversible masking of pore-forming proteins for macromolecular delivery |
| 01/03/2014 | WO2014004639A1 Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use |
| 01/03/2014 | WO2014004586A1 Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells |
| 01/03/2014 | WO2014004549A2 Anti-mesothelin binding proteins |
| 01/03/2014 | WO2014004427A2 Anti-egfr antibodies and uses thereof |
| 01/03/2014 | WO2014004336A2 Split inteins, conjugates and uses thereof |
| 01/03/2014 | WO2014004281A1 Purification of biological molecules |
| 01/03/2014 | WO2014003552A1 Binding molecules targeting pathogens |
| 01/03/2014 | WO2014003142A1 Antibody |
| 01/03/2014 | WO2014003137A1 High-affinity antibody, and production method therefor |
| 01/03/2014 | WO2014003008A1 Novel histamine liberator contained in human sweat |
| 01/03/2014 | WO2014002035A2 A human monoclonal antibody against the vp1 protein of jc virus |
| 01/03/2014 | WO2014001967A1 Anti-tofacitinib antibodies and uses thereof for drug monitoring |
| 01/03/2014 | WO2014001570A1 Composition for use in mycobacteria vaccination |
| 01/03/2014 | WO2014001557A1 A method for identifying compounds of therapeutic interest |
| 01/03/2014 | WO2014001368A1 Il-17 antagonist antibodies |
| 01/03/2014 | WO2014001326A1 Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof |
| 01/03/2014 | WO2014001325A1 Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof |
| 01/03/2014 | WO2014001324A1 Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof |
| 01/03/2014 | WO2013171505A3 Transgenic non-human vertebrate for the in vivo production of dual specificity|immunoglobulins or hypermutated heavy chain only immunoglobulins |
| 01/03/2014 | WO2013084151A3 Antibodies for epidermal growth factor receptor 3 (her3) directed to domain iii and domain iv of her3 |
| 01/03/2014 | CA2877882A1 Split inteins, conjugates and uses thereof |
| 01/03/2014 | CA2877850A1 Binding molecules targeting pathogens |
| 01/03/2014 | CA2877598A1 A human monoclonal antibody against the vp1 protein of jc virus |
| 01/03/2014 | CA2876697A1 Anti-egfr antibodies and uses thereof |
| 01/03/2014 | CA2803566A1 Syringe |
| 01/02/2014 | US20140007292 Novel Insecticidal Proteins and Methods for Their Use |
| 01/02/2014 | US20140005368 Low Fucose Cell Lines And Uses Thereof |
| 01/02/2014 | US20140005366 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 01/02/2014 | US20140005365 Antibody to a mutant g-csf for diagnosis of cancer |
| 01/02/2014 | US20140005361 FC-Interferon-Beta Fusion Proteins |
| 01/02/2014 | US20140005098 Igfbp-3 derivatives and uses thereof |
| 01/02/2014 | US20140004623 Assay for Benzylpiperazine and Metabolites |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004565 Cell-based bioprocessing |
| 01/02/2014 | US20140004542 Systems and Methods for Anti-PAX8 Antibodies |
| 01/02/2014 | US20140004536 Method for detecting cellular dna damage and antibody against cell surface antigen responsive to dna strand breaks |
| 01/02/2014 | US20140004156 Biological inhibitors of ror1 capable of inducing cell death |
| 01/02/2014 | US20140004132 Immunotherapy of cancer using genetically engineered gd2-specific t cells |
| 01/02/2014 | US20140004130 MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo |
| 01/02/2014 | US20140004128 Anti-il-18 antibodies and their uses |
| 01/02/2014 | US20140004127 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors |
| 01/02/2014 | US20140004125 Il-1beta binding antibodies and fragments thereof |
| 01/02/2014 | US20140004124 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
| 01/02/2014 | US20140004123 Monoclonal antibody production by ebv transformation of b cells |
| 01/02/2014 | US20140004122 Methods for treating or preventing cholesterol related disorders |
| 01/02/2014 | US20140004121 Anti-mesothelin binding proteins |
| 01/02/2014 | US20140004120 Novel anti-dr5 antibody |
| 01/02/2014 | US20140004119 Agonistic antibodies to trkc receptors and uses thereof |
| 01/02/2014 | US20140004118 Clostridium difficile antibodies |